Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Applied Therapeutics Inc
(NQ:
APLT
)
1.280
-0.010 (-0.78%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Applied Therapeutics Inc
< Previous
1
2
3
4
5
Next >
(APLT) - Analyzing Applied Therapeutics's Short Interest
December 06, 2024
Via
Benzinga
Netflix To Rally More Than 7%? Here Are 10 Top Analyst Forecasts For Monday
December 02, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 29, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
November 29, 2024
Via
Benzinga
Regulatory Setback For Applied Therapeutics' Lead Program, FDA Highlights Deficiencies In Clinical Application
November 29, 2024
FDA rejected Applied Therapeutics' Govorestat for galactosemia, citing NDA deficiencies. The company plans discussions for resubmission or appeal.
Via
Benzinga
Exposures
Product Safety
Why Applied Therapeutics Stock Is Skyrocketing Today
September 18, 2024
Investors are cheering good news from the FDA.
Via
The Motley Fool
Applied Therapeutics: Q4 Earnings Insights
March 06, 2024
Via
Benzinga
Steelcase Reports Weak Sales, Joins American Healthcare REIT And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
September 19, 2024
Via
Benzinga
Dow Jumps Over 100 Points; Fed Cuts Interest Rates By 0.5%
September 18, 2024
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Crude Oil Moves Lower; PowerFleet Shares Spike Higher
September 18, 2024
Via
Benzinga
Exposures
Fossil Fuels
Russell 2000 Outpaces S&P 500 As Small Caps Anticipate Fed's Interest Rate Move
September 18, 2024
Small-cap stocks are surging ahead of the expected interest rate cut by the Federal Reserve, outperforming their larger-cap counterparts. However, potential for gains may be hindered by sluggish...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Applied Therapeutics Stock Soars As FDA Scraps Panel Meeting For Its Inherited Metabolic Disorder Drug
September 18, 2024
Applied Therapeutics stock rises as the FDA no longer requires an Advisory Committee meeting, keeping the Priority Review on track, with the PDUFA target date set for November 28.
Via
Benzinga
Exposures
Product Safety
Applied Therapeutics, PowerFleet, VF Corp, Victoria's Secret And Other Big Stocks Moving Higher On Wednesday
September 18, 2024
Via
Benzinga
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
September 12, 2024
Via
Benzinga
Rare Disease-Focused Applied Therapeutics' Lead Candidate Govorestat Has Blockbuster Potential, Analyst Sees 140% Stock Upside
July 31, 2024
William Blair has initiated coverage on Applied Therapeutics highlighting its focus on rare diseases such as galactosemia, SORD deficiency, and diabetic cardiomyopathy. With govorestat (AT-007) poised...
Via
Benzinga
CrossFirst Bankshares Posts Q2 Earnings, Joins Owens & Minor, Reddit And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
July 16, 2024
Via
Benzinga
Top 4 Health Care Stocks That May Keep You Up At Night This Month
June 11, 2024
Via
Benzinga
APLT Stock Earnings: Applied Therapeutics Meets EPS, Misses Revenue for Q1 2024
May 09, 2024
APLT stock results show that Applied Therapeutics met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
FDA Presses Delay Button For Applied Therapeutics' First Potential Marketed Drug For Rare Disease
April 01, 2024
FDA extends the review period for Applied Therapeutics' NDA for govorestat, targeting Classic Galactosemia treatment. The new action date is set for November 28, 2024. Applied Therapeutics anticipates...
Via
Benzinga
Exposures
Product Safety
Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket
April 01, 2024
Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transaction with TRG to go private at $6.29 per share in cash. Doma Holdings...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 01, 2024
Via
Benzinga
Oxford Industries Posts Weak Results, Joins Applied Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
April 01, 2024
U.S. stock futures were higher this morning, with the Dow futures gaining by over 100 points on Monday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Friday's After-Market Session
March 29, 2024
Via
Benzinga
EQT, Genie Energy And Other Big Stocks Moving Lower On Monday
March 11, 2024
U.S. stocks were lower, with the Dow Jones index falling more than 150 points on Monday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Advance Auto Parts Reports Q4 Results, Joins B&G Foods, Vipshop, ADT And Other Big Stocks Moving Higher On Wednesday
February 28, 2024
U.S. stocks were lower, with the Dow Jones index falling around 100 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
February 28, 2024
Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.
Via
Benzinga
FDA Grants Review Date For Applied Therapeutics' First Commercial Product For Rare Metabolic Disorder
February 28, 2024
Applied Therapeutics surges as FDA grants Priority Review to govorestat (AT-007) for Galactosemia treatment. If approved, it would be the first medication for Galactosemia. APLT also submits MAA to...
Via
Benzinga
Exposures
Product Safety
Why Is Coupang (CPNG) Stock Up 4% Today?
February 28, 2024
Coupang stock is rallying on Wednesday as investors in CPNG celebrate the company beating out EPS and revenue estimates for Q4.
Via
InvestorPlace
Why Is Applied Therapeutics (APLT) Stock Up 59% Today?
February 28, 2024
Applied Therapeutics stock is rising higher on Wednesday alongside heavy trading of APLT following an update from the FDA.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
February 19, 2024
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.